000 01333 a2200397 4500
005 20250518064248.0
264 0 _c20201023
008 202010s 0 0 eng d
022 _a1536-4844
024 7 _a10.1093/ibd/izz218
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHarnoss, Jonathan M
245 0 0 _aProlyl Hydroxylase Inhibition Mitigates Pouchitis.
_h[electronic resource]
260 _bInflammatory bowel diseases
_c01 2020
300 _a192-205 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aHumans
650 0 4 _aPouchitis
_xenzymology
650 0 4 _aProlyl Hydroxylases
_xchemistry
650 0 4 _aProlyl-Hydroxylase Inhibitors
_xtherapeutic use
700 1 _aGebhardt, Jasper M
700 1 _aRadhakrishnan, Praveen
700 1 _aLeowardi, Christine
700 1 _aBurmeister, Julius
700 1 _aHalligan, Doug N
700 1 _aYuan, Shuai
700 1 _aKennel, Kilian B
700 1 _aStrowitzki, Moritz J
700 1 _aSchaible, Anja
700 1 _aLasitschka, Felix
700 1 _aTaylor, Cormac T
700 1 _aSchneider, Martin
773 0 _tInflammatory bowel diseases
_gvol. 26
_gno. 2
_gp. 192-205
856 4 0 _uhttps://doi.org/10.1093/ibd/izz218
_zAvailable from publisher's website
999 _c30207371
_d30207371